BAUSCH + LOMB CORP (BLCO.CA) Stock Fundamental Analysis
Canada - TSX:BLCO - CA0717051076 - Common Stock
22.34 CAD
+1.2 (+5.68%)
BLCO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 16 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BLCO while its profitability can be described as average. BLCO has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BLCO had positive earnings in the past year.
In the past year BLCO had a positive cash flow from operations.
In multiple years BLCO reported negative net income over the last 5 years.
BLCO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of BLCO (-1.97%) is better than 100.00% of its industry peers.
BLCO's Return On Equity of -4.24% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
The Return On Invested Capital of BLCO (0.60%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLCO is in line with the industry average of 0.60%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.97% | ||
| ROE | -4.24% | ||
| ROIC | 0.6% |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
1.3 Margins
The Operating Margin of BLCO (2.04%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of BLCO has declined.
With a decent Gross Margin value of 59.68%, BLCO is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.04% | ||
| PM (TTM) | N/A | ||
| GM | 59.68% |
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
Compared to 1 year ago, BLCO has more shares outstanding
The number of shares outstanding for BLCO has been increased compared to 5 years ago.
The debt/assets ratio for BLCO is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.83, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
BLCO has a better Altman-Z score (0.83) than 87.50% of its industry peers.
BLCO has a Debt/Equity ratio of 0.77. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
The Debt to Equity ratio of BLCO (0.77) is better than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.83 |
ROIC/WACC0.08
WACC7.32%
2.3 Liquidity
A Current Ratio of 1.55 indicates that BLCO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.55, BLCO is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
BLCO has a Quick Ratio of 1.55. This is a bad value and indicates that BLCO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.98, BLCO is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.51%.
Looking at the last year, BLCO shows a small growth in Revenue. The Revenue has grown by 6.23% in the last year.
BLCO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.87% yearly.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
3.2 Future
The Earnings Per Share is expected to grow by 24.11% on average over the next years. This is a very strong growth
BLCO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.93% yearly.
EPS Next Y-12.99%
EPS Next 2Y14.18%
EPS Next 3Y18.8%
EPS Next 5Y24.11%
Revenue Next Year6.68%
Revenue Next 2Y6.25%
Revenue Next 3Y5.69%
Revenue Next 5Y4.93%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 36.62, BLCO can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BLCO is valued cheaper than 100.00% of the companies in the same industry.
BLCO is valuated rather expensively when we compare the Price/Earnings ratio to 26.13, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 19.56, BLCO is valued on the expensive side.
Based on the Price/Forward Earnings ratio, BLCO is valued cheaply inside the industry as 93.75% of the companies are valued more expensively.
BLCO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.35, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.62 | ||
| Fwd PE | 19.56 |
4.2 Price Multiples
BLCO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLCO is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 19.45 |
4.3 Compensation for Growth
BLCO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BLCO's earnings are expected to grow with 18.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.18%
EPS Next 3Y18.8%
5. Dividend
5.1 Amount
BLCO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:BLCO (11/5/2025, 7:00:00 PM)
22.34
+1.2 (+5.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.05%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap7.91B
Revenue(TTM)4.98B
Net Income(TTM)-273000000
Analysts72
Price Target21.47 (-3.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-179.28%
Min EPS beat(2)-360.35%
Max EPS beat(2)1.79%
EPS beat(4)3
Avg EPS beat(4)-86.95%
Min EPS beat(4)-360.35%
Max EPS beat(4)6.68%
EPS beat(8)6
Avg EPS beat(8)-36.55%
EPS beat(12)9
Avg EPS beat(12)-22.21%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.73%
Min Revenue beat(2)-3.07%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.08%
Revenue beat(8)3
Avg Revenue beat(8)0.41%
Revenue beat(12)6
Avg Revenue beat(12)0.75%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.93%
PT rev (3m)3.48%
EPS NQ rev (1m)-1.7%
EPS NQ rev (3m)-9.53%
EPS NY rev (1m)0%
EPS NY rev (3m)9.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.62 | ||
| Fwd PE | 19.56 | ||
| P/S | 1.14 | ||
| P/FCF | N/A | ||
| P/OCF | 30.1 | ||
| P/B | 0.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.45 |
EPS(TTM)0.61
EY2.73%
EPS(NY)1.14
Fwd EY5.11%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)0.74
OCFY3.32%
SpS19.52
BVpS25.7
TBVpS-6.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.97% | ||
| ROE | -4.24% | ||
| ROCE | 0.83% | ||
| ROIC | 0.6% | ||
| ROICexc | 0.61% | ||
| ROICexgc | 1.95% | ||
| OM | 2.04% | ||
| PM (TTM) | N/A | ||
| GM | 59.68% | ||
| FCFM | N/A |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
ROICexc(3y)1.5%
ROICexc(5y)1.8%
ROICexgc(3y)4.98%
ROICexgc(5y)6.16%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.32 | ||
| Cap/Depr | 81.82% | ||
| Cap/Sales | 7.18% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 35.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.83 |
F-Score4
WACC7.32%
ROIC/WACC0.08
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-12.99%
EPS Next 2Y14.18%
EPS Next 3Y18.8%
EPS Next 5Y24.11%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.68%
Revenue Next 2Y6.25%
Revenue Next 3Y5.69%
Revenue Next 5Y4.93%
EBIT growth 1Y-49.24%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year45.28%
EBIT Next 3Y21.2%
EBIT Next 5Y15.69%
FCF growth 1Y-189.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.47%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%
BAUSCH + LOMB CORP / BLCO.CA FAQ
What is the fundamental rating for BLCO stock?
ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA.
What is the valuation status for BLCO stock?
ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for BAUSCH + LOMB CORP?
BAUSCH + LOMB CORP (BLCO.CA) has a profitability rating of 6 / 10.
What is the valuation of BAUSCH + LOMB CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BAUSCH + LOMB CORP (BLCO.CA) is 36.62 and the Price/Book (PB) ratio is 0.87.
Can you provide the financial health for BLCO stock?
The financial health rating of BAUSCH + LOMB CORP (BLCO.CA) is 3 / 10.